New England Institute for Clinical Research

Stamford, Connecticut 06905

0 studies enrolling now · 29 studies all time

What they study most

Alzheimer Disease, Alzheimer Disease (AD), Alzheimer's Disease, Alzheimers Disease, Cerebral Palsy, Cervical Dystonia, Chronic Cluster Headache, Chronic Migraine, Headache, Dementia, Dementia With Lewy Bodies, Episodic Cluster Headache, Episodic Migraine

Studies at this site

• Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine — Running, not enrolling
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine — Completed
• Open Label, 6-month Study for High Frequency and Chronic Migraine, — Running, not enrolling
• AMG 334 20160172 Pediatric Migraine PK Study. — Completed
• An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention — Status unconfirmed
• Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine — Completed
• A Study of LY3451838 in Participants With Migraine — Completed
• A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab — Completed
• Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients — Completed
• Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) — Completed
• A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease — Completed
• Study To Evaluate the Efficacy, Safety and Tolerability of E2027 (Hereinafter Referred to as Irsenontrine) in Participants With Dementia With Lewy Bodies — Completed
• Fasudil fOr redUcing elopemeNt and Spatial Disorientation — Completed
• Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache — Completed
• A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) — Completed
• 12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine — Completed
• A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease — Stopped early
• A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia — Stopped early
• A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine — Completed
• A Study of Galcanezumab in Participants With Chronic Cluster Headache — Completed
• A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura — Completed
• A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease — Stopped early
• A Study Of Galcanezumab In Participants With Episodic Cluster Headache — Completed
• BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity — Completed
• A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache — Completed
• Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache — Status unconfirmed
• A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine — Completed